Objective Given limited regional data, we investigate the state‐wide epidemiology, renal and
patient outcomes for lupus nephritis (LN) in Western Australia (WA). Methods Patients …

Objective There is a paucity of population‐based studies investigating the epidemiology of
lupus nephritis (LN) in the US and long‐term secular trends of the disease and its outcomes …

Objectives There is paucity of population-based studies investigating the epidemiology of
lupus nephritis (LN) in the US and long-term secular trends of the disease and its outcomes …

Objective. To determine nephritis outcomes in a prospective multi-ethnic/racial SLE
inception cohort. Methods. Patients in the Systemic Lupus International Collaborating Clinics …

Objective There is limited knowledge on the relative impact of lupus nephritis (LN) on
morbidity and mortality in population-based systemic lupus erythematous (SLE) cohorts …

LN, an immunocyte and immune complex driven inflammation of the nephrons, is a major
manifestation of SLE [1]. The availability of efficacious and safe immunosuppressive agents …

Background Lupus nephritis (LN) is a serious complication of systemic lupus erythematosus
(SLE), associated with considerable morbidity and an increased risk of end-stage kidney …

Objective Renal involvement is a major complication of systemic lupus erythematosus (SLE)
and is a strong determinant of morbidity and mortality. There have been no previous studies …

Objectives To investigate the current demographic, clinical and histological characteristics of
patients with lupus nephritis (LN) in Western Australia (WA) with regards to their predictive …

Objective To determine if the incidence of endstage renal disease (ESRD) due to lupus
nephritis has decreased from 1996 to 2004. Methods Patients age 15 years or older with …